Michael Scolaro

Michael Scolaro

Aug 22, 2017

Group 6 Copy 15
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Are endangered tigers in Nepal threatened by diseases from dogs and cats?

    Through our wildlife health work in Nepal, we have seen sick tigers that show symptoms similar to canine distemper...

    Are American Women of Childbearing Age Changing Their Behaviors in Response to the Zika Virus Outbreak?

    The Zika virus outbreak is an international public health emergency, and is linked to microcephaly and Guillain...

    Backer Badge Funded